Philip Kern
Clinical trials sponsored by Philip Kern, explained in plain language.
-
Could a bladder pill help prevent diabetes?
Disease control Recruiting nowThis phase 2 trial is testing whether mirabegron, a drug currently used for overactive bladder, can improve glucose tolerance and activate brown fat in people with prediabetes. Researchers will enroll 65 adults with a BMI of 27-45 and prediabetes. Participants will take mirabegro…
Phase: PHASE2 • Sponsor: Philip Kern • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could a bladder drug and an ED drug fix prediabetes?
Disease control Recruiting nowThis study tests whether mirabegron (a bladder medication) and tadalafil (used for erectile dysfunction) can improve blood sugar control in people with prediabetes and obesity. About 96 adults will take one or both drugs or a placebo for 14 weeks. The goal is to see if these drug…
Phase: PHASE4 • Sponsor: Philip Kern • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC